190 related articles for article (PubMed ID: 30951865)
1. Study of the efficacy of N-methyl glucamine antimoniate (Sb
Ribeiro JBP; Miranda-Vilela AL; Amorim AAS; Garcia RD; Moreira JR; Gomes CM; Takano GHS; de Oliveira GMF; Lima AV; da Silva ICR; Sampaio RNR
Photodiagnosis Photodyn Ther; 2019 Jun; 26():261-269. PubMed ID: 30951865
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice.
Ribeiro JBP; Miranda-Vilela AL; Graziani D; Gomes MRA; Amorim AAS; Garcia RD; de Souza Filho J; Tedesco AC; Primo FL; Moreira JR; Lima AV; Sampaio RNR
Photodiagnosis Photodyn Ther; 2016 Mar; 13():282-290. PubMed ID: 26306406
[TBL] [Abstract][Full Text] [Related]
3. Topical photodynamic therapy with chloroaluminum phthalocyanine liposomes is as effective as systemic pentavalent antimony in the treatment of experimental cutaneous leishmaniasis.
Lopes SC; Silva RA; Novais MV; Coelho LD; Ferreira LA; Souza PE; Tedesco A; Azevedo RB; Aguiar MG; Oliveira MC
Photodiagnosis Photodyn Ther; 2019 Dec; 28():210-215. PubMed ID: 31454712
[TBL] [Abstract][Full Text] [Related]
4. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
Moosavian SA; Fallah M; Jaafari MR
Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic process induced by chloro-aluminum phthalocyanine nanoemulsion in glioblastoma.
Castilho-Fernandes A; Lopes TG; Primo FL; Pinto MR; Tedesco AC
Photodiagnosis Photodyn Ther; 2017 Sep; 19():221-228. PubMed ID: 28599959
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of zinc phthalocyanine nanoemulsions for use in photodynamic therapy for Leishmania spp.
de Oliveira de Siqueira LB; da Silva Cardoso V; Rodrigues IA; Vazquez-Villa AL; Dos Santos EP; da Costa Leal Ribeiro Guimarães B; Dos Santos Cerqueira Coutinho C; Vermelho AB; Junior ER
Nanotechnology; 2017 Feb; 28(6):065101. PubMed ID: 28071592
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using ultradeformable liposomes loaded with chlorine aluminum phthalocyanine against L. (V.) braziliensis experimental models.
Escobar P; Vera AM; Neira LF; Velásquez AO; Carreño H
Exp Parasitol; 2018 Nov; 194():45-52. PubMed ID: 30257189
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis].
Costa Filho AV; Lucas IC; Sampaio RN
Rev Soc Bras Med Trop; 2008; 41(4):424-7. PubMed ID: 18853022
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis.
Ramos TD; Silva JD; da Fonseca-Martins AM; da Silveira Pratti JE; Firmino-Cruz L; Maciel-Oliveira D; Dos-Santos JS; Tenorio JIN; de Araujo AF; Freire-de-Lima CG; Diaz BL; Cruz FF; Rocco PRM; de Matos Guedes HL
Stem Cell Res Ther; 2020 Aug; 11(1):374. PubMed ID: 32867857
[TBL] [Abstract][Full Text] [Related]
10. Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark.
Montanari J; Maidana C; Esteva MI; Salomon C; Morilla MJ; Romero EL
J Control Release; 2010 Nov; 147(3):368-76. PubMed ID: 20727925
[TBL] [Abstract][Full Text] [Related]
11. Phototoxic effect of aluminium-chlorine and aluminium-hydroxide phthalocyanines on Leishmania (l.) amazonensis.
Nesi-Reis V; Navasconi TR; Lera-Nosone DSSL; Oliveira EL; Barbosa PM; Caetano W; Silveira TGV; Aristides SMA; Hioka N; Lonardoni MVC
Photodiagnosis Photodyn Ther; 2018 Mar; 21():239-245. PubMed ID: 29275066
[TBL] [Abstract][Full Text] [Related]
12. Liposomal zinc phthalocyanine as a potential agent for photodynamic therapy of leishmaniasis.
Sazgarnia A; Bahreyni-Toosi MH; Layegh P; Rajabi O; Ghodsinia RM
Indian J Dermatol Venereol Leprol; 2010; 76(4):417-8. PubMed ID: 20657130
[No Abstract] [Full Text] [Related]
13. The use of azythromycin and N-methyl glucamine for the treatment of cutaneous Leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL6 mice.
Sampaio RN; Lucas IC; Costa Filho AV
An Bras Dermatol; 2009; 84(2):125-8. PubMed ID: 19503979
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis.
Kawakami MYM; Zamora LO; Araújo RS; Fernandes CP; Ricotta TQN; de Oliveira LG; Queiroz-Junior CM; Fernandes AP; da Conceição EC; Ferreira LAM; Barros ALB; Aguiar MG; Oliveira AEMFM
Biomed Pharmacother; 2021 Feb; 134():111109. PubMed ID: 33341050
[TBL] [Abstract][Full Text] [Related]
15. The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.
Gonçalves-Oliveira LF; Souza-Silva F; de Castro Côrtes LM; Veloso LB; Santini Pereira BA; Cysne-Finkelstein L; Lechuga GC; Bourguignon SC; Almeida-Souza F; da Silva Calabrese K; Ferreira VF; Alves CR
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():101-108. PubMed ID: 31430693
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis.
Peixoto JF; Gonçalves-Oliveira LF; Souza-Silva F; de Castro Côrtes LM; Finkelstein LC; Dias-Lopes G; Patricio BFC; Lima CGS; Rocha HVA; da Silva FC; Ferreira VF; Pereira BAS; Alves CR
Int J Parasitol Drugs Drug Resist; 2024 Apr; 24():100525. PubMed ID: 38359731
[TBL] [Abstract][Full Text] [Related]
17. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
Carvalho SH; Frézard F; Pereira NP; Moura AS; Ramos LMQC; Carvalho GB; Rocha MOC
Trop Med Int Health; 2019 Apr; 24(4):380-391. PubMed ID: 30681239
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial.
Machado PRL; Ribeiro CS; França-Costa J; Dourado MEF; Trinconi CT; Yokoyama-Yasunaka JKU; Malta-Santos H; Borges VM; Carvalho EM; Uliana SRB
Trop Med Int Health; 2018 Sep; 23(9):936-942. PubMed ID: 29924907
[TBL] [Abstract][Full Text] [Related]
19. In vitro phototoxicity of ultradeformable liposomes containing chloroaluminum phthalocyanine against New World Leishmania species.
Hernández IP; Montanari J; Valdivieso W; Morilla MJ; Romero EL; Escobar P
J Photochem Photobiol B; 2012 Dec; 117():157-63. PubMed ID: 23123595
[TBL] [Abstract][Full Text] [Related]
20. Effects of photodynamic therapy mediated by nanoemulsion containing chloro-aluminum phthalocyanine: a histologic and immunohistochemical study in human gingiva.
de Moraes M; de Vasconcelos RC; Longo JP; Muehlmann LA; de Azevedo RB; Lemos TM; Costa Ade L
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):592-7. PubMed ID: 26521145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
